Name: UMIN ID:
Unique ID issued by UMIN | UMIN000015131 |
---|---|
Receipt number | R000017600 |
Scientific Title | A study of prophylactic oral steroids for fatigue and malaise due to regorafenib treatment for unresectable metastatic colorectal cancer: a randomized, placebo-controlled, double-blind Phase 2 clinical study (KSCC1402/HGCSG1402) |
Date of disclosure of the study information | 2014/09/11 |
Last modified on | 2017/04/30 18:42:43 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/09/11 20:49:25 | ||
2 | Update | 2014/09/11 20:50:43 | UMIN ID1 |
|
3 | Update | 2014/10/15 10:46:17 | Organization Organization Category of Funding Organization |
|
4 | Update | 2014/10/16 16:56:43 | Institutions |
|
5 | Update | 2014/10/17 10:27:56 | Public title Public title Acronym Acronym |
|
6 | Update | 2014/11/07 18:50:23 | Recruitment status Anticipated trial start date |
|
7 | Update | 2014/11/10 09:49:19 | Organization |
|
8 | Update | 2015/01/05 22:48:48 | Institutions |
|
9 | Update | 2015/03/11 09:11:58 | Institutions |
|
10 | Update | 2015/04/13 09:15:32 | Institutions |
|
11 | Update | 2015/05/22 08:14:19 | Email |
|
12 | Update | 2015/09/11 13:29:43 | Institutions |
|
13 | Update | 2016/03/29 11:13:41 | Recruitment status |
|
14 | Update | 2016/05/21 11:15:33 | Name of primary person or sponsor Organization Organization |
|
15 | Update | 2017/04/30 18:42:43 | Recruitment status Results Results |